MedTrace Logo

Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's Disease

NCT04259203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-12-05

No results posted yet for this study

Summary

This study evaluates the efficacity of Erickson hypnosis in the treatment of chronic pain in patients with Parkinson's disease. Half of participants will follow a 2-month Erickson hypnosis protocole, while the other half will benefit from the usual care.

Conditions

Interventions

BEHAVIORAL

Erickson hypnosis

Erickson hypnosis sessions performed by an experienced hypnotherapist, according to a pre-established protocol : 5 sessions (1 per week). Between each session : exercise of auto-hypnosis by the patient himself, at home

Sponsors & Collaborators

  • France Parkinson Association

    collaborator OTHER

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Luc Defebvre, MD,PhD · University Hospital, Lille

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-08
Primary Completion
2024-08-16
Completion
2024-08-16

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04259203 on ClinicalTrials.gov